Yidebang, a China-based online medical care portal backed by diversified conglomerate Fosun, has secured more than RMB100m ($14.1m) in series B funding.
Venture capital firm Sinovation Ventures led the round, which also featured private equity firm Shanghai Qijing Investment.
Founded in 2015, Yidebang has created an online platform that allows users to secure diagnoses, book medical treatment and get prescriptions filled. It concentrates on rural areas where medical services may be more thinly spread.
The company raised $9m in a November 2017 series A round led by Frontline BioVentures and backed by fellow VC firms Marathon Venture Partners, before Fosun subsidiary Fosun Pharma led a $14.6m series A-plus round in August 2018.
